Cite
The Role of Nuclear Medicine Imaging with F-18-FDG PET/CT, Combined In-111-WBC/(99)mTc-Nanocoll, and Tc-99m-HDP SPECT/CT in the Evaluation of Patients with Chronic Problems after TKA or THA in a Prospective Study
MLA
Aleksyniene, Ramune, et al. The Role of Nuclear Medicine Imaging with F-18-FDG PET/CT, Combined In-111-WBC/(99)MTc-Nanocoll, and Tc-99m-HDP SPECT/CT in the Evaluation of Patients with Chronic Problems after TKA or THA in a Prospective Study. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1312848407&authtype=sso&custid=ns315887.
APA
Aleksyniene, R., Iyer, V., Bertelsen, H. C., Nilsson, M. F., Khalid, V., Schonheyder, H. C., Larsen, L. H., Nielsen, P. T., Kappel, A., Thomsen, T. R., Lorenzen, J., Ørsted, I., Simonsen, O., Jordal, P. L., & Rasmussen, S. (2022). The Role of Nuclear Medicine Imaging with F-18-FDG PET/CT, Combined In-111-WBC/(99)mTc-Nanocoll, and Tc-99m-HDP SPECT/CT in the Evaluation of Patients with Chronic Problems after TKA or THA in a Prospective Study.
Chicago
Aleksyniene, Ramune, Victor Iyer, Henrik Christian Bertelsen, Majbritt Frost Nilsson, Vesal Khalid, Henrik Carl Schonheyder, Lone Heimann Larsen, et al. 2022. “The Role of Nuclear Medicine Imaging with F-18-FDG PET/CT, Combined In-111-WBC/(99)MTc-Nanocoll, and Tc-99m-HDP SPECT/CT in the Evaluation of Patients with Chronic Problems after TKA or THA in a Prospective Study.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1312848407&authtype=sso&custid=ns315887.